{"name":"TransCode Therapeutics","slug":"transcode-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTFB2bkRhMmdubVJ2bkJ0cGlzSURWWXJBSE5NN0U3WmZJQnUtWWE4dG9ldHBEdEJZc25aNUF0aTQ5OG5MNk5lYlRXSlBsQQ?oc=5","date":"2026-04-02","type":"pipeline","source":"Meyka","summary":"TransCode Therapeutics, Inc. (RNAZ) Competitors - Meyka","headline":"TransCode Therapeutics, Inc. (RNAZ) Competitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOb1k4WV9uTUFWdUNXVE1HR19EVE91TGlXRmc4QktKWkJMNUFSMDhkeDFlMVBnX25GQnlMaWhRU0gtazF2MWY0MGJFS1N4MDZwQS1xT2YwWUtaWFN0RHZBX29Mc0cydkVIQmNKWHJwYWx3M0hhc3M0cWFrNnRHYnJzSEo0LUNfN0lUUjdtUmhETGhzakxycGM4SmlKeVVOczFZcmU1Z0ZMdzItelFjcDc5Qy1KYjVYUHRMTS1HSTBFSmZiMkl5Uzd0b3d5WXNmMUw3bDNCOE1ROVo3bUpTTWpYaEF2SEJ6Q0ZX?oc=5","date":"2025-12-22","type":"pipeline","source":"PR Newswire","summary":"TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors - PR Newswire","headline":"TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOLXNoZVFEeUY4N2dXTkxNME5ZYThOX2VaWTkxTFZYOTQ1UzN5WWZhUlh1Nm13UkFSMm9VbjBzM0hxd3ZyWmxFdXJOYVhFTjNwdHRvT0RZT1JwczJWXzdkRnI1Wlg5NWhQUEcyd2VsQzlTSVg1aW92V3pWNjhSYXlXVFBqWkljU09ycHh1bTFTUy1qTHJWMXF1Wl9ucHNMLXdpR2VaZVRwRnFiNTR3WmtENlI3TzdIdFlvWF8xV18wcEgzdw?oc=5","date":"2025-12-22","type":"pipeline","source":"Investing.com","summary":"TransCode Therapeutics appoints Jack E. Stover to board of directors - Investing.com","headline":"TransCode Therapeutics appoints Jack E. Stover to board of directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNcW1qMFliZlhCQmtwOVM0UXlxNUdPc3R5RzVNVEZWVHFCbDYxbGU1RzZ3cVpfaTg1b1lWTnREVE1wQ3cxM3BfMDZuSWI0Z2NoZXpSV2JFZW1pOGNpc2M2UkZlQ1E1T2pHbll6bk5VTHo0aVlWRy0taTQ3MkNEcEIyTnQ0OVJyUWxhM1pKN1VoMFVQMGZGNnhveTN4VVNHRUhj?oc=5","date":"2025-10-29","type":"pipeline","source":"The ASCO Post","summary":"Zenocutuzumab Potential Explored in NRG1 -Positive Cholangiocarcinoma - The ASCO Post","headline":"Zenocutuzumab Potential Explored in NRG1 -Positive Cholangiocarcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5EdzhLelpvb01RTkNGZ1A2VkNlSDBYNGlqYzNKME5PR1J1bzVxOUllbVJHSWFKZW1VM1VjdEdUdXdhaTAxZ2RsQWFSeXBZUTltRmNZ?oc=5","date":"2025-10-14","type":"pipeline","source":"FirstWord Pharma","summary":"Spotlight On: The key cancer drugs to watch at ESMO 2025 - FirstWord Pharma","headline":"Spotlight On: The key cancer drugs to watch at ESMO 2025","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-08","type":"pipeline","source":"PR Newswire","summary":"TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metast","headline":"TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxQV3p0WXY5ZXdmOG1nQ0hYMFQyVWs2SDhvWjZYNm1XOGRBLXNPdzEtWGo5WTJvSVVRVi1icS05U1hQcUhGRGxGQWxxdF9qejJuWm1BYlRJT2dYaEVmTzkyclRQWllNSmVMSEZheW9TREtoQ05vTzUxQkdSSXE2UFFJOXNHSkNIU0RhU0szNVVTX1FIRU4zU1RLeWh6Q2d1LVZqRmIxNlJUZWFvSWplYWlWTjJoTW5DdnFYXy1Zc01QQzNiZmxSWVRjWU1ZQnFieE1sbDFwZG9JVGhOOVhZelpWM0ZMMXluU2VrdDBEVDliV0RyRmhZblVDREpvVkRhWGdhZTROUWZFaVlhM3FOWWJuRDZXemRkd21Tc2RDOEsxR3BHcW1saEItV1ZvUkxDendudDZBZHFwUlNCRzc2NVBCYmdrMzc?oc=5","date":"2025-08-28","type":"trial","source":"globenewswire.com","summary":"Antisense Oligonucleotide Therapeutics Clinical Trial - globenewswire.com","headline":"Antisense Oligonucleotide Therapeutics Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AJBVV95cUxPN202TUJ4Nm1xZ3AwUEFZbjh0cGl1NWc5WDJFLW03VHhlZnV0R28wOFR4UC0wNlJnSHV6WVY4aG9mdEtDZ1phbHdKWnUyaEhuTzUteERfdkpJdnA1S1VZVGp3TlpwcXhxeEJZeEttTzYwZlNKTHBtZ0dXVGhtSnZZeUs3bkxhTFpVZ2d0c3d5Mm83eGtlRmZJU3FseW5lYVhoeVBESV8zRW9fb1FPTk1jd1ZUb1dyeGlrTFBuMUhCcFBzTnI2azJadG9fWHlxVS1RX0Roc3NNbnIwS19aVEJXbE5zQUJBUHVwdDhhYlluVGZhcXlRVW1wak5xazJ2bFlNMmFzaV9oVENvOWRsTEJFdVRwc2Z3TURveTlIRkJRQXpLV3JWTldMRnBwZG1EdEJSVGdTVlhUVktvS3drSHFrTGFZUmhpcnpOUXl2cEN5OERFZVpE?oc=5","date":"2025-06-17","type":"trial","source":"globenewswire.com","summary":"Oligonucleotides Clinical Trial Pipeline Analysis - globenewswire.com","headline":"Oligonucleotides Clinical Trial Pipeline Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNQ0lwMzdrNWgzOTJ4X1pfNnJ3VE5vaWpJYy1mOHdCbV93X3hXTkhDbkxWRTc2bWIwU0dRQzBNd1BnS3V6aWVwWFU2NHkzRmVuRTdLVzY0cERheEF3WWoyeFMzcDFuUlpXZVFheGMxUjktNEh4NG1aQ2NrZ1djT1UzZWdTLXdsQWthem1scUdWYmVNeHFpT3dXREMybDVjMzROX05NdUMxMmJ2bzVwWndrdUNhQlI0Snh4UmlMUHpjRXBhSVJ3WXZrenFBNEM2QQ?oc=5","date":"2025-05-28","type":"pipeline","source":"PR Newswire","summary":"TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - PR Newswire","headline":"TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1QdVFFNjdrdWNtcVhuMUMxcnpPVVV6c0pieHltRy1wdU1DTmJoOVprcTQtei1YZ3JKMTFQZ0pTQUU2SmJKZ2tiaXcwaWVMMVpFcFhz?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"RNAZ Stock Price, News & Analysis - Stock Titan","headline":"RNAZ Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE9FSXI1QkhDM3gzSUxydGR3MVduNUJVdGpiZ0kwbWVBdGtaQ28yaWJhX3k0d3hoQ183RUhtb3M1aTdLQzJKR2JGMFFyejRsUWl3bmFUZUtDSVVFMHh3bWprVHo4NHc?oc=5","date":"2024-11-26","type":"pipeline","source":"Labiotech.eu","summary":"Seven miRNA-focused companies pioneering new therapies in 2024 - Labiotech.eu","headline":"Seven miRNA-focused companies pioneering new therapies in 2024","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}